trending Market Intelligence /marketintelligence/en/news-insights/trending/KONsb7298mOz2pt3l58THw2 content esgSubNav
In This List

Versartis chief development officer to leave

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Versartis chief development officer to leave

Versartis Inc. said Chief Development Officer Colin Hislop's employment will be terminated, effective Oct. 20.

Hislop joined Versartis in 2016 from Anthera Pharmaceuticals Inc., where he served as the company's chief medical officer.